Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cystic Fibrosis: Causes, Diagnosis, and Treatment

Key takeaways - Cystic fibrosis (CF) is a genetic condition caused by mutations in the CFTR gene, which makes mucus abnormally thick and sticky. This buildup damages the lungs, pancreas, liver, and intestines over time. - Common symptoms include persistent cou

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Key takeaways

  • Cystic fibrosis (CF) is a genetic condition caused by mutations in the CFTR gene, which makes mucus abnormally thick and sticky. This buildup damages the lungs, pancreas, liver, and intestines over time.
  • Common symptoms include persistent cough with thick mucus, wheezing, shortness of breath, recurrent lung infections, greasy stools, constipation, and inadequate weight gain in children.
  • While there’s no cure, treatment may include antibiotics, mucus-thinning medications, CFTR modulators, chest physical therapy, and nutritional support. Many people with CF now live into their 40s and 50s with proper management.

Cystic fibrosis (CF) is a serious genetic condition that causes severe damage to the respiratory and digestive systems. This damage often results from a buildup of thick, sticky mucus in the organs.

Regular, daily care can help manage CF, but there’s no one treatment plan that will work for everyone. With a treatment plan specific to your needs, you can still live a full life, attend school, and have a career.

In this article, we take a look at the symptoms, causes, diagnosis, and treatment of cystic fibrosis.

Cystic fibrosis affects the cells that produce sweat, mucus, and digestive enzymes. Normally, these fluids are thin and smooth like olive oil. They lubricate your organs and tissues, keeping them from getting too dry.

According to the Cystic Fibrosis Foundation, more than 30,000 people in the United States have cystic fibrosis, and another 1,000 people are diagnosed with it every year. CF is a progressive condition, so it gets worse over time.

If you have CF, a genetic mutation increases the thickness of mucus and other body fluids. When this happens, the thicker fluids can interrupt the function of organs — like the movement of air through your lungs. This can trap bacteria and lead to infections.

In more advanced cases, people with CF may have complications like respiratory failure and malnutrition.

It’s critical to get treatment for CF right away. Early diagnosis and treatment can improve quality of life and lengthen one’s life span.

Screening tests and treatment methods have improved in recent years, so many people with CF can now live into their 40s and 50s.

The symptoms of cystic fibrosis can vary depending on the person and the severity of their condition. The age at which symptoms develop can also differ.

Symptoms may appear in infancy, but for other children, symptoms may not begin until after puberty or even later in life. As time passes, the symptoms associated with the disease may get better or worse.

One of the first signs of CF is a strong, salty taste to the skin. Parents of children with CF have mentioned noticing this saltiness when kissing their children.

Other symptoms of CF result from complications that affect the:

  • lungs
  • pancreas
  • liver
  • other glandular organs

Respiratory problems

The thick, sticky mucus associated with CF often blocks the passageways that carry air into and out of the lungs. This can cause the following symptoms:

  • wheezing
  • persistent cough that produces thick mucus or phlegm
  • shortness of breath, especially when exercising
  • recurrent lung infections
  • stuffy nose
  • stuffy sinuses

Digestive problems

The abnormal mucus can also plug the channels that carry the enzymes produced by the pancreas to the small intestine. Without these digestive enzymes, the intestine can’t absorb the necessary nutrients from food. This can result in:

  • greasy, foul-smelling stools
  • constipation
  • nausea
  • abdominal swelling
  • loss of appetite
  • insufficient weight gain in children
  • delayed growth in children

CF occurs as a result of a defect in what’s called the “cystic fibrosis transmembrane conductance regulator” gene, or CFTR gene. This gene controls the movement of water and salt in and out of your body’s cells.

A sudden mutation, or change, in the CFTR gene causes your mucus to become thicker and stickier than it’s supposed to be.

This abnormal mucus increases the amount of salt in your sweat and builds up in various organs throughout the body, including the:

  • intestines
  • pancreas
  • liver
  • lungs

Different defects can affect the CFTR gene. The type of defect is associated with the severity of CF. The damaged gene is passed on to the child from their parents.

In order to have CF, a child must inherit one copy of the gene from each biological parent. If they only inherit a copy of the gene from one parent, they won’t develop the disease. However, they’ll be a carrier of the defective gene, which means they may pass the gene on to their own biological children.

How likely you are to inherit CF depends on several factors.

Anyone can inherit CF if their parents carry the gene. However, carriers usually have just one copy of a defective gene and may never experience symptoms or even know they carry the gene.

According to the Cystic Fibrosis Foundation, about 10 million people in the United States are carriers of the gene for CF, yet only about 30,000 have active disease.

Although carriers won’t have active disease, the children of two carriers have a much higher risk. To be exact, if both your parents carry the cystic fibrosis gene, there is a:

In terms of ancestry or ethnic backgrounds, a

People who have a family history of CF are also at an increased risk because it’s an inherited disorder.

The diagnosis of CF requires clinical symptoms consistent with CF in at least one organ system and evidence of CFTR dysfunction. This evidence is usually based on abnormal results from a sweat chloride test or the presence of mutations in the CFTR gene.

Clinical symptoms are not required for infants identified through newborn screening. Other diagnostic tests that may be performed include:

  • Immunoreactive trypsinogen (IRT) test: The IRT test is a standard newborn screening test that checks the blood for abnormal levels of the protein called IRT. A high level of IRT may be a sign of CF. However, further testing is required to confirm the diagnosis.
  • Sweat chloride test: The sweat chloride test is the most commonly used test for diagnosing CF. It checks for increased levels of salt in the sweat. The test is performed by using a chemical that makes the skin sweat when triggered by a weak electric current. Sweat is collected on a pad or paper and then analyzed. A diagnosis of CF is made if the sweat is saltier than normal.
  • Sputum test: During a sputum test, the doctor takes a sample of mucus. The sample can confirm the presence of a lung infection. It can also show the types of germs that are present and determine which antibiotics work best to treat them.
  • Chest X-ray: A chest X-ray is useful for revealing swelling in the lungs due to blockages in the respiratory passageways.
  • CT scan: A CT scan creates detailed images of the body using a combination of X-rays taken from different directions. These images allow your doctor to view internal structures, such as the liver and pancreas, making it easier to assess the extent of organ damage caused by CF.
  • Pulmonary function tests (PFTs): PFTs determine whether your lungs are working properly. The tests can help measure how much air can be inhaled or exhaled and how well the lungs transport oxygen to the rest of the body. Any abnormalities in these functions may indicate CF.

Although there’s no cure for CF, there are various treatments available that may help relieve symptoms and reduce the risk of complications.

Medications

  • Antibiotics: A doctor may prescribe antibiotics to get rid of a lung infection and prevent a future infection. Antibiotics are usually given as liquids, tablets, or capsules. In more severe cases, injections or infusions of antibiotics can be given intravenously (through a vein).
  • Mucus-thinning medications: These make the mucus thinner and less sticky. They also help you cough up the mucus so it leaves the lungs. This significantly improves lung function.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs, such as ibuprofen (Advil), have a limited role as an agent to reduce airway inflammation. The Cystic Fibrosis Foundation suggests the use of high-dose ibuprofen in children ages 6 through 17 with CF who have good lung function. Ibuprofen is not recommended for people with more severe lung function abnormalities or those who are older than age 18.
  • Bronchodilators: Bronchodilators relax the muscles around the tubes that carry air to the lungs, which helps increase airflow. You can take this medication through an inhaler or a nebulizer.
  • Cystic fibrosis transmembrane conductance regulator (CFTR) modulators: CFTR modulators are a class of drugs that can improve the function of the defective CFTR gene. These drugs represent an important advance in the management of CF because they target the function of the mutated CFTR gene rather than its clinical effects. All patients with CF should undergo CFTR gene studies to determine if they carry one of the mutations approved for CFTR modulator drugs. Most of the available data are in patients less than 12 years old and in patients with mild or moderate CF lung disease.

Surgical procedures

  • Bowel surgery: This is an emergency surgery that involves the removal of a section of the bowel. It may be performed to relieve a blockage in the bowels.
  • Feeding tube: Cystic fibrosis may interfere with digestion and keep you from absorbing nutrients from food. A feeding tube to supply nutrition can be passed through the nose or surgically inserted directly into the stomach.
  • Double lung transplant: When trying to medically manage your CF, you can no longer maintain lung health and function, this procedure can improve the length and quality of life for a person with CF.

Transplant benefits

A lung transplant may be an option to improve and extend your life. However, the CF gene mutation will remain in your body, affecting other organs even after you’ve received new lungs.

There are also a number of things to consider when weighing transplantation as an option. There’s a risk of infection and rejection of the organ, and you will have to take medications that suppress your immune system for the rest of your life.

Chest physical therapy

Chest therapy helps loosen the thick mucus in the lungs, making it easier to cough up. It’s typically performed 1 to 4 times per day.

A common technique involves placing the head over the edge of a bed and clapping with cupped hands along the sides of the chest.

Mechanical devices may also be used to clear mucus. These include:

  • a chest clapper, which imitates the effects of clapping with cupped hands along the sides of the chest
  • an inflatable vest, which vibrates at a high frequency to help remove chest mucus

Home care

CF can prevent the intestines from absorbing necessary nutrients from food.

If you have CF, you might need more calories per day than people who don’t have the disease. You may also need to take pancreatic enzyme capsules with every meal.

Your doctor may also recommend antacids, multivitamins, and a diet high in fiber and salt.

If you have CF, it’s important to:

  • Drink plenty of fluids, because they can help thin the mucus in the lungs.
  • Exercise regularly to help loosen mucus in the airways. Walking, biking, and swimming are great options.
  • Avoid smoke, pollen, and mold whenever possible. These irritants can make symptoms worse.
  • Get influenza and pneumonia vaccinations regularly.

CF cannot be prevented. However, genetic testing should be performed for couples who have CF or have relatives with the disease.

Genetic testing can determine a child’s risk of CF by testing samples of blood or saliva from each parent. Tests can also be performed on you if you’re pregnant and concerned about your baby’s risk.

The outlook for people with CF has improved dramatically in recent years, largely due to advances in treatment. Today, many people with the disease live into their 40s and 50s, and even longer in some cases.

However, there’s no cure for CF, so lung function will steadily decline over time. The resulting damage to the lungs can cause severe breathing problems and other complications.

Next steps

If you or a loved one are believed to have CF, the first steps you should take are to confirm the diagnosis and to become educated on the condition.

A number of tests can be performed to confirm a diagnosis, and your doctor or healthcare professional should be able to discuss how advanced your condition is and what treatment plans will work best.

While there’s no cure for CF, there are some facilities that provide more specialized CF care. Additionally, you will want to make sure to maintain your health and preserve your strength by doing things like:

  • practicing strict hygiene to avoid infection
  • avoiding people who are sick
  • making sure you have adequate nutrition

It takes a whole team of healthcare professionals, a good support system, and the cooperation of employers, schools, and insurers to get people with CF the care they need.

There are a number of online resources and even online or local support groups that can help you or your loved ones cope the with demands of living with — or caring for someone with — CF.

Finding help

There are many organizations that can offer support and resources for living with CF. Below are some available resources:

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What Is Cystic Fibrosis?

Cystic fibrosis (CF) is a genetic disorder, which means you get it from your parents at birth. It affects your lungs, pancreas, and other organs. CF changes the way chloride (salt) moves through the cells of your body. This causes the mucus (which should be thin and slippery) in various organs to become thick and sticky. Over time, this thick mucus builds up inside your airways, making it hard to breathe. The mucus traps germs and leads to infections and inflammation. It can also cause severe, long-term damage to the lungs and lead to respiratory failure (inability to breathe normally) and death. In the pancreas, the thick mucus caused by CF prevents the release of digestive enzymes when you eat. This leads to malnutrition and poor growth. CF can also cause liver disease, reproductive problems, and cystic fibrosis-related diabetes (CFRD). More than 40,000 people in the U.S. live with CF. Doctors diagnose about 1,000 new cases each year. Today, more than half of the CF population is aged 18 or older, and new treatments have expanded the life expectancy by decades.

Source: www.webmd.com ↗
02When to see a doctor

If you or your child has symptoms of cystic fibrosis — or if someone in your family has CF — talk with your healthcare professional about testing for the condition. Make an appointment with a doctor who has skills and experience in treating CF. CF requires regular follow-up with your healthcare professional, at least every three months. Call your healthcare professional if you have new or worsening symptoms, such as more mucus than usual or a change in the mucus color, lack of energy, weight loss, or severe constipation. Get medical care right away if you're coughing up blood, have chest pain or trouble breathing, or have severe stomach pain and bloating. Call 911 or your local emergency number or go to the emergency department at a hospital if: You're having a hard time catching your breath or talking. Your lips or fingernails turn blue or gray. Others notice that you're not mentally alert.

Source: www.mayoclinic.org ↗
03What to expect from your doctor

After getting detailed information about the symptoms and your family's medical history, your healthcare professional may order tests to help with diagnosis and plan treatment. Your healthcare professional also may ask questions, such as: What symptoms are you or your child having? When did the symptoms start? Does anything make the symptoms better or worse? Has anyone in your family ever had cystic fibrosis? Has growth been average and weight been stable? Cystic fibrosis. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/cystic-fibrosis. Accessed Aug. 8, 2024. Bronchiectasis. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/bronchiectasis. Accessed Aug. 8, 2024. FAQs: Cystic fibrosis: Prenatal screening and diagnosis. American College of Obstetricians and Gynecologists. https://www.acog.org/womens-health/faqs/cystic-fibrosis-prenatal-screening-and-diagnosis. Accessed Aug. 8, 2024. Ferri FF. Cystic fibrosis. In: Ferri's Clinical Advisor 2025. Elsevier; 2025. https://www.clinicalkey.com. Accessed Aug. 8, 2024. Kliegman RM, et al., eds. Cystic fibrosis. In: Nelson Textbook of Pediatrics. 22nd ed. Elsevier; 2025. https://www.clinicalkey.com. Accessed Aug. 8, 2024. Kellerman RD, et al. Cystic fibrosis. In: Conn's Current Therapy 2024. Elsevier; 2024. https://www.clinicalkey.com. Accessed Aug. 8, 2024. Lockwood CJ, et al., eds. Respiratory diseases in pregnancy. In: Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 8, 2024. Ong T, et al. Cystic fibrosis: A review. JAMA. 2023; doi:10.1001/jama.2023.8120. Rubin R. Tackling the misconception that cystic fibrosis is a "white people's disease." JAMA. 2021; doi:10.1001/jama.2021.5086. Care centers. Cystic Fibrosis Foundation. https://www.cff.org/managing-cf/care-centers. Accessed Aug. 8, 2024. Trikafta (prescribing information). Vertex Pharmaceuticals Inc.; 2023. https://www.trikafta.com/. Accessed Aug. 8, 2024. Symdeko (prescribing information). Vertex Pharmaceuticals Inc.; 2023. https://www.symdeko.com/. Accessed Aug. 8, 2024. Orkambi (prescribing information). Vertex Pharmaceuticals Inc.; 2023. https://www.orkambi.com/. Accessed Aug. 8, 2024. Kalydeco (prescribing information). Vertex Pharmaceuticals Inc.; 2023. https://www.kalydeco.com/. Accessed Aug. 8, 2024. Pilewski JM. Update on lung transplantation for cystic fibrosis. Clinics in Chest Medicine. 2022; doi:10.1016/j.ccm.2022.07.002. Fridell JA, et al. Pancreas transplantation for cystic fibrosis: A frequently missed opportunity. Clinical Transplantation. 2021; doi:10.1111/ctr.14371. Wadsworth LE, et al. Non-invasive ventilation is associated with long-term improvements in lung function and gas exchange in cystic fibrosis adults with hypercapnic respiratory failure. Journal of Cystic Fibrosis. 2021; doi:10.1016/j.jcf.2021.05.011. Allscripts EPSi. Mayo Clinic. Medical review (expert opinion). Mayo Clinic. Oct. 18, 2024.

Source: www.mayoclinic.org ↗
04How Was It Studied for the Treatment of Cystic Fibrosis?

The effectiveness and safety of Alyftrek for cystic fibrosis was studied in two randomized trials (Trials VX20-121-102 and VX20-121-103). These studies compared Alyftrek to another standard treatment for cystic fibrosis ( elexacaftor /tezacaftor/ivacaftor). People in the studies first received elexacaftor/tezacaftor/ivacaftor for four weeks, then were assigned to continue this treatment or switch to Alyftrek for 52 weeks. Trial VX20-121-102 included 398 people with F508del-minimal function genotypes. The median (middle) age was 31 and 41% of people were female; most people in the study were White (97%), while 1% were Black or African American, and <1% were Asian. Trial VX20-121-103 included 573 people with F508del-F508del, F508del-residual function, F508del-gating, or other responsive mutations. The median age was 33.1 and 49% of people in the study were female. Most people were White (93%), 1% were Black or African American, and <1% each were Southeast Asian, other Asian, or American Indian/Alaska Native. The study found that Alyftrek was similar to elexacaftor/tezacaftor/ivacaftor in improving lung function (measured by forced expiratory volume in 1 second [FEV1 %]), with similar results seen in both studies. Additionally, Alyftrek led to greater reductions in sweat chloride, a key measure of CFTR function, in both studies. The results of these studies suggest that Alyftrek is a promising alternative to elexacaftor/tezacaftor/ivacaftor, offering similar lung function benefits and helping CFTR to work better. The safety profile of Alyftrek was similar to that of elexacaftor/tezacaftor/ ivacaftor . The most common side effects included worsening lung infections (28%), cough (23%), COVID-19 (22%), and the common cold (nasopharyngitis; 21%). Serious side effects were similar between groups, with 14% of people treated with Alyftrek and 16% of people treated with standard treatment experiencing severe reactions. High liver enzymes were slightly more common in the Alyftrek group, but overall safety findings were similar to those seen in other studies. Your results may differ from what was seen in clinical studies.

Source: www.webmd.com ↗
05What is it used for?

A sweat test is used to diagnose cystic fibrosis (CF).

Source: medlineplus.gov ↗
Research context

Read sources and limitations before applying a claim.

Research and Statistics: Who Has Cystic Fibrosis?

About 40,000 people are living with cystic fibrosis in the United States, and there are approximately 105,000 people with CF worldwide. (3) More than 75 percent of people with the disease are diagnosed by age 2, and more than half of all people living with cystic fibrosis are 18 or older. CF occurs predominantly in white populations, at a rate of 1 in 2,500 births. Between 2 and 5 percent of white people are carriers of the CFTR gene variant but have no overt clinical signs of disease. The disease is less common among African Americans, occurring at the much lower frequency of approximately 1 out of 17,000 births. (15) CF gene variants are most prevalent in persons of northern and central European ancestries or of Ashkenazi Jewish descent. They are rarely found in Native Americans, Asians, or native Africans. (16) CF is equally common among men and women, but women patients fare significantly worse than male patients with the disease. The median survival age for female CF patients is about three years younger than it is for men, but the reasons for the poorer survival rates among women are not completely understood. (17)

Source: everydayhealth.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →